Andrew Perry
Corporate Officer/Principal at G1 THERAPEUTICS, INC.
Net worth: 304 751 $ as of 30/04/2024
Profile
Andrew Perry is currently the Chief Commercial Officer at G1 Therapeutics, Inc. He previously worked as the Vice President of US Marketing at ViiV Healthcare Ltd.
Mr. Perry is a graduate of the University of Glasgow and The University of Sheffield.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
G1 THERAPEUTICS, INC.
0.15% | 13/05/2024 | 78,951 ( 0.15% ) | 304 751 $ | 30/04/2024 |
Andrew Perry active positions
Companies | Position | Start |
---|---|---|
G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2021 |
Former positions of Andrew Perry
Companies | Position | End |
---|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - |
Training of Andrew Perry
University of Glasgow | Graduate Degree |
The University of Sheffield | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
G1 THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Andrew Perry